Cargando…
Caracterización molecular de pacientes con cáncer colorrectal
INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Nacional de Salud
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414253/ https://www.ncbi.nlm.nih.gov/pubmed/35866738 http://dx.doi.org/10.7705/biomedica.5957 |
_version_ | 1784775945686614016 |
---|---|
author | Humberto Afanador, Carlos Palacio, Katherine Andrea Isaza, Luis Fernando Ahumada, Enoc Ocampo, Carlos Mauricio Muñetón, Carlos Mario |
author_facet | Humberto Afanador, Carlos Palacio, Katherine Andrea Isaza, Luis Fernando Ahumada, Enoc Ocampo, Carlos Mauricio Muñetón, Carlos Mario |
author_sort | Humberto Afanador, Carlos |
collection | PubMed |
description | INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic colorectal cancer. MATERIALS AND METHODS: We conducted mutation analyses of the APC, KRAS, TP53 y BRAF genes using Sanger sequencing techniques; microsatellite instability was determined by capillary electrophoresis with five STR genetic markers while the methylation status of the MHL1 promotor gene was analyzed using methylation-specific PCR. RESULTS: APC, KRAS, and TP53 genes mutation frequency was 18.1%, 25%, and 4.5%, respectively; the somatic mutations detected were located more frequently in the right colon. The frequency of microsatellite instability was 27.2% and 73.1% of the tumors had the MHL1 gene methylated while 91.6% of microsatellite instability-positive tumors had the methylated MLH1 gene. The mutation profile of microsatellite stability tumors APC, KRAS, and TP53 genes was more frequent than in the microsatellite instability-positive tumors. The methylation of the MLH1 gene was the most predominant molecular alteration. CONCLUSIONS: We identified molecular alterations in different genetic pathways of the colorectal cancer patients evaluated, which are common in the carcinogenesis of this cancer. These patients showed a different mutational profile compared to other populations. Our findings confirm the molecular heterogeneity described in the development of colorectal cancer. |
format | Online Article Text |
id | pubmed-9414253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Instituto Nacional de Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-94142532022-08-26 Caracterización molecular de pacientes con cáncer colorrectal Humberto Afanador, Carlos Palacio, Katherine Andrea Isaza, Luis Fernando Ahumada, Enoc Ocampo, Carlos Mauricio Muñetón, Carlos Mario Biomedica Artículo Original INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic colorectal cancer. MATERIALS AND METHODS: We conducted mutation analyses of the APC, KRAS, TP53 y BRAF genes using Sanger sequencing techniques; microsatellite instability was determined by capillary electrophoresis with five STR genetic markers while the methylation status of the MHL1 promotor gene was analyzed using methylation-specific PCR. RESULTS: APC, KRAS, and TP53 genes mutation frequency was 18.1%, 25%, and 4.5%, respectively; the somatic mutations detected were located more frequently in the right colon. The frequency of microsatellite instability was 27.2% and 73.1% of the tumors had the MHL1 gene methylated while 91.6% of microsatellite instability-positive tumors had the methylated MLH1 gene. The mutation profile of microsatellite stability tumors APC, KRAS, and TP53 genes was more frequent than in the microsatellite instability-positive tumors. The methylation of the MLH1 gene was the most predominant molecular alteration. CONCLUSIONS: We identified molecular alterations in different genetic pathways of the colorectal cancer patients evaluated, which are common in the carcinogenesis of this cancer. These patients showed a different mutational profile compared to other populations. Our findings confirm the molecular heterogeneity described in the development of colorectal cancer. Instituto Nacional de Salud 2022-05-01 /pmc/articles/PMC9414253/ /pubmed/35866738 http://dx.doi.org/10.7705/biomedica.5957 Text en https://creativecommons.org/licenses/by/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons |
spellingShingle | Artículo Original Humberto Afanador, Carlos Palacio, Katherine Andrea Isaza, Luis Fernando Ahumada, Enoc Ocampo, Carlos Mauricio Muñetón, Carlos Mario Caracterización molecular de pacientes con cáncer colorrectal |
title | Caracterización molecular de pacientes con cáncer colorrectal |
title_full | Caracterización molecular de pacientes con cáncer colorrectal |
title_fullStr | Caracterización molecular de pacientes con cáncer colorrectal |
title_full_unstemmed | Caracterización molecular de pacientes con cáncer colorrectal |
title_short | Caracterización molecular de pacientes con cáncer colorrectal |
title_sort | caracterización molecular de pacientes con cáncer colorrectal |
topic | Artículo Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414253/ https://www.ncbi.nlm.nih.gov/pubmed/35866738 http://dx.doi.org/10.7705/biomedica.5957 |
work_keys_str_mv | AT humbertoafanadorcarlos caracterizacionmoleculardepacientesconcancercolorrectal AT palaciokatherineandrea caracterizacionmoleculardepacientesconcancercolorrectal AT isazaluisfernando caracterizacionmoleculardepacientesconcancercolorrectal AT ahumadaenoc caracterizacionmoleculardepacientesconcancercolorrectal AT ocampocarlosmauricio caracterizacionmoleculardepacientesconcancercolorrectal AT munetoncarlosmario caracterizacionmoleculardepacientesconcancercolorrectal |